From Shock to Awe (2019)

Tickets »

Let op! De webshop sluit 1 uur voor de voorstelling. Neem contact op met de kassa via 070-2119988

DNR Filmclub - Festival Sacred Songs

vr 14 okt | 20:15 uur | KLEINE ZAAL | €7 | Ooievaarspas 50%

DNR Filmclub

From Shock to Awe (2018)
14th October | tijd 20:15
 Directed by Luc Coté
1 hr 27 min | USA | In English with Dutch subtitles

From Shock to Awe asks, ‘How do we heal our deepest wounds?’ An intimate and raw look at the transformational journey of two combat veterans suffering from severe trauma as they abandon pharmaceuticals to seek relief through the mind-expanding world of psychedelics. Recent scientific research, coupled with a psychedelic renaissance, reveals that these substances can be used to heal PTSD (Post-Traumatic Stress Disorder) for individuals and their families. Beyond the personal stories, From Shock to Awealso raises fundamental questions about war, the pharmaceutical industry, and the US legal system.



From Shock to Awe stelt de vraag: "Hoe helen we onze diepste wonden"? Een intieme en rauwe blik op de transformerende reis van twee gevechtsveteranen die lijden aan ernstige trauma's als ze farmaceutische middelen verlaten om verlichting te zoeken via de geestverruimende wereld van psychedelica. Recent wetenschappelijk onderzoek, in combinatie met een psychedelische renaissance, onthult dat deze stoffen kunnen worden gebruikt om PTSS (Post-Traumatische Stress Stoornis) te genezen voor individuen en hun families. Naast de persoonlijke verhalen, roept From Shock to Awe ook fundamentele vragen op over oorlog, de farmaceutische industrie en het Amerikaanse rechtssysteem.


Lecture and speaker for Shock to Awe

Psychedelics for the treatment of psychotrauma: What do we know about the risks and benefits?

Cultures around the world have used psychedelic plants and fungi in healing rituals and spiritual ceremonies since a very long time. After their (re)discovery in the West, scientists and therapists started studying psychedelic compounds such as psilocybin (the active ingredient in magic mushrooms) and LSD as potential treatments for psychiatric disorders, with promising results. However, this research came to a halt when most of these compounds became illegal around 1970. In the last two decades, there has been a revival of this research. Currently, universities all over the world are studying psychedelic-assisted therapies for the treatment of a wide variety of indications, including depression, addiction and posttraumatic stress disorder. This presentation will give an overview of these developments. What do we know about these powerful compounds? How do they work? And what do these studies tell us about their potential risks and benefits?

Erwin Krediet is a researcher and psychologist that has studied the therapeutic properties of psychedelics for almost 20 years. He is the vice-chair of the OPEN Foundation, a Dutch non-profit organization that has been advancing psychedelic research and therapies since 2007. As part of his PhD, he is currently developing and investigating psychedelic-assisted therapies for the treatment of PTSD, at ARQ National Psychotrauma Centre and the Leiden University Medical Center. Before starting his PhD research, he was a research associate at Eleusis Therapeutics, where he worked on several phase 1 and 2 clinical trials with LSD and psilocybin. He also is a lead adherence rater for European MDMA-assisted psychotherapy trials at the Multidisciplinary Association for Psychedelic Studies (MAPS), and an advisory board member of the International Society for Substance-assisted Psychotherapy.